Fames ac turpis egestas maecenas. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Donec odio. Nullam malesuada erat ut turpis. Suspendise urna nibh, viverra non, semper suscipit i posuere a.

The study is conducted by:

Read the published article in Härryda-Posten here (Swedish).

Härryda-Posten publishes interview about REAL AD

Read the article in Partille Tidning here (Swedish).

Partille Tidning publishes interview about the REAL AD study

Watch the clip to learn more about blood tests for Alzheimer's disease why the REAL AD study is so important right now.

Professors Kaj Blennow and Henrik Zetterberg tell us more about their roles in the study

REAL AD - Kaj och Henrik

Read the article published in Alekuriren here (Swedish).

Alekuriren writes about REAL AD, including an interview with the head of Närhälsan in Älvängen

Read the article published in Torslanda-Öckerötidningen here (in Swedish).

Torslanda-Öckerötidningen writes about the REAL AD study

Listen to the interview with Professor Michael Schöll in P4 Göteborg here (from 1:39:37).

Interview about the REAL AD study in P4 Göteborg

Professor Michael Schöll was invited and interviewed by P4 Skaraborg to talk about the REAL AD study. Listen to the radio interview here (from 1:38:40, in Swedish).

GUJ2-2024English.pdf

Read the article about the study in the GU (University of Gothenburg) journal here.

GU Journal writes about the REAL AD study

Göteborgs-Posten has published an article about the study, with an interview with the study leader Professor Michael Schöll. Read the article here (in Swedish).

Read the article published in Skaraborgsbygden here (in Swedish).

Article about REAL AD published in Skaraborgsbygden

Early detection of Alzheimer's disease is crucial to provide effective treatment and care. Click here to listen to P4 Väst's radio interview with Professor Michael Schöll, leader of the REAL AD study, where he highlights the importance of the study.

Blood samples and online memory tests could offer a simple and cost-effective way to screen people for the risk of developing Alzheimer's. The REAL AD study is investigating just this in the recently launched study in collaboration with Närhälsan and others.

Professor Michael Schöll highlights the importance of the study in P4 Väst

The University of Gothenburg has published an interview with Professor Michael Schöll, click here to read the interview.

The interview discusses, among other things, that the study focuses on the potential for early diagnosis based on digital cognitive tests and blood markers. If the combination of the tools works to detect early signs of disease in the general population, the hope is that they will be used in primary care in the future to follow individuals over time and identify Alzheimer's with greater certainty and much earlier than is often the case today.

Also published in Medicinsk access, Neurologi i Sverige, Akademiliv, and Sahlgrenska Liv.

The University of Gothenburg writes about the launch of REAL AD

Today we launch the REAL AD study!!! After years of preparation, we are now welcoming participants and hope that many will join us!

Here, professor Michael Schöll, one of the researchers behind the study, welcomes you to REAL AD (video in Swedish):

Välkommen till REAL AD-studien!

Click here to listen to P4 Halland's radio interview with Professor Kaj Blennow, one of the researchers behind the REAL AD study.

Prof. Kaj Blennow explains how a simple blood test has great potential for early detection of Alzheimer's disease. This method is now being tested on a large scale in the REAL AD study. 

Even those who live in the Halland region but can get to one of Närhälsan's healthcare centres in Västra Götaland are warmly welcomed to the REAL AD study!  

Radio interview about the REAL AD study with professor Kaj Blennow

The Swedish Alzheimer's Foundation supports the REAL AD study and encourages everyone in the target group to apply!

The Swedish Alzheimer Foundation supports the REAL AD study

Läkemedelsvärlden published an interview today with Professor Michael Schöll. The article discusses, among other things, why the study is so relevant today and its details. Click here to read the article (in Swedish).

Professor Michael Schöll interviewed by Läkemedelsvärlden about the REAL AD study


The REAL AD study will investigate the possibility of detecting Alzheimer's disease early on in primary care using new digital tools and simple blood tests. On March 12th, we had a fantastic kickoff meeting meeting where fifty key individuals gathered at Sahlgrenska Academy in Gothenburg, as well as via a link from Berlin and London.

REAL AD is an innovative study that is based on an active collaboration between leading actors in academia (University of Gothenburg, University College London), Sahlgrenska University Hospital and primary care in Region Västra Götaland (Närhälsan), industry (Alzpath, Bioarctic, Cognitron, Neotiv, Roche), e-services in healthcare (ADDI Medical AB) and communication (Wenderfalck Kommunikation AB).

Read more about this groundbreaking study here.

Read about the latest developments in the REAL AD study and other breakthroughs in Alzheimer's disease research.

News feed